Efficacy and Safety of Combined Thread Embedding Acupuncture With Auricular Acupuncture for GERD
Evaluating Efficacy and Safety of Combined Thread Embedding and Auricular Acupuncture in Gastroesophageal Reflux Disease With Liver Qi Invading Stomach Pattern: A Randomized Controlled Trial
1 other identifier
interventional
66
1 country
1
Brief Summary
Gastroesophageal reflux disease (GERD) is increasingly prevalent today. Proton-pump inhibitors (PPIs) are the primary treatment, yet their effectiveness remains limited. Various acupuncture methods have shown promise in treating GERD. Among these, thread embedding acupuncture (TEA) and auricular acupuncture (AA) offer the advantage of prolonged treatment per intervention, significantly reducing healthcare visits for procedures, particularly beneficial for conditions requiring extended therapy. This has led to the widespread application of TEA and AA in GERD treatment. However, evidence supporting their effectiveness remains inconclusive. In this study, we aim to assess the efficacy and safety of combining TEA with AA for treating GERD. According to traditional medicine, treatment should be pattern-based. Thus, we will focus on patients exhibiting the Liver Qi Invading Stomach pattern, as reports indicate its prevalence among GERD patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 27, 2023
CompletedFirst Posted
Study publicly available on registry
December 5, 2023
CompletedStudy Start
First participant enrolled
December 6, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 18, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 18, 2024
CompletedMarch 20, 2024
March 1, 2024
3 months
November 27, 2023
March 18, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
The proportion of heartburn resolution
Heartburn resolution is assessed through patient inquiry during each follow-up examination.
Day 0 and after every week during 4-week treatment (day 0, day 7, day 14, day 21, day 28)
Secondary Outcomes (6)
The proportion of regurgitation resolution
Day 0 and after every week during 4-week treatment (day 0, day 7, day 14, day 21, day 28)
Chang in the Gastroesophageal Reflux disease Questionnaire (GerdQ) score
Day 0 and after every week during 4-week treatment (day 0, day 7, day 14, day 21, day 28)
Chang in the Frequency Scale for the Symptoms of GERD (FSSG) score
Day 0 and after every two week during 4-week treatment (day 0, day 14, day 28)
Chang in the Gastroesophageal Reflux Disease-Health Related Quality of Life (GERD-HRQL) score
Day 0 and after every two week during 4-week treatment (day 0, day 14, day 28)
Changes in the number of antacid packets used
Day 0 and after every week during 4-week treatment (day 0, day 7, day 14, day 21, day 28)
- +1 more secondary outcomes
Study Arms (2)
Acupuncture + Standard treatment
EXPERIMENTALStandard treatment plus thread embedding acupuncture and auricular acupuncture
Standard treatment
ACTIVE COMPARATORStandard treatment
Interventions
Thread Embedding Acupuncture is applied at acupoints including CV-12, CV-13, ST-36, PC-6, BL-17, BL-18, BL-21 on both sides of the body every 2 weeks, totaling 2 sessions over 4 weeks of intervention.
Auricular acupuncture is administered using adhesive patches with small needles (0.25 x 1.3 mm) placed at acupoints TF4, AH6, CO12, CO4, CO2 once a week, totaling 4 sessions over the 4-week intervention period.
Standard treatment, continuously administered over the 4-week intervention period, involves standard doses of proton pump inhibitors, additional antacids as needed, and lifestyle modifications.
Eligibility Criteria
You may qualify if:
- Men or women aged from 18 to 60 Years
- GerdQ score of eight or higher
- Having heartburn and/or regurgitation on two days per week or more
- Diagnosis of GERD with Liver Qi Invading Stomach Pattern
You may not qualify if:
- Any prior endoscopy-confirmed structural diseases
- Uncontrolled inflammatory bowel disease, chronic or genetic conditions, alcohol or drug abuse history
- Alarming symptoms indicating gastric cancer, complicated ulcers, or serious illnesses
- History of esophageal or gastrointestinal surgery
- Current use of medications impacting GERD treatment or assessment
- Recent (within two weeks) Western Medicine or Traditional Medicine treatment for GERD
- History of hypersensitivity reactions to any components involved in the intervention
- Pregnancy or breastfeeding
- Current participation in any other clinical trials
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Medical Center HCMC - Branch no.3, University of Medicine and Pharmacy at Ho Chi Minh City
Ho Chi Minh City, 700000, Vietnam
Related Publications (7)
Maret-Ouda J, Markar SR, Lagergren J. Gastroesophageal Reflux Disease: A Review. JAMA. 2020 Dec 22;324(24):2536-2547. doi: 10.1001/jama.2020.21360.
PMID: 33351048BACKGROUNDLuo Z, Hu X, Chen C, Zhu L, Zhang W, Shen Y, He J. Effect of Catgut Embedment in Du Meridian Acupoint on Mental and Psychological Conditions of Patients with Gastroesophageal Reflux Disease. Evid Based Complement Alternat Med. 2020 Sep 22;2020:5415813. doi: 10.1155/2020/5415813. eCollection 2020.
PMID: 33029166BACKGROUNDKatz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013 Mar;108(3):308-28; quiz 329. doi: 10.1038/ajg.2012.444. Epub 2013 Feb 19. No abstract available.
PMID: 23419381BACKGROUNDHunt R, Armstrong D, Katelaris P, Afihene M, Bane A, Bhatia S, Chen MH, Choi MG, Melo AC, Fock KM, Ford A, Hongo M, Khan A, Lazebnik L, Lindberg G, Lizarzabal M, Myint T, Moraes-Filho JP, Salis G, Lin JT, Vaidya R, Abdo A, LeMair A; Review Team:. World Gastroenterology Organisation Global Guidelines: GERD Global Perspective on Gastroesophageal Reflux Disease. J Clin Gastroenterol. 2017 Jul;51(6):467-478. doi: 10.1097/MCG.0000000000000854. No abstract available.
PMID: 28591069BACKGROUNDSun QH, Li TT, Huang MT, Wang MY, Xiao X, Bai XH. [Acupoint selection rules in treating gastroesophageal reflux disease with acupuncture in China based on data mining]. Zhongguo Zhen Jiu. 2020 Dec 12;40(12):1374-8. doi: 10.13703/j.0255-2930.20191107-0003. Chinese.
PMID: 33415885BACKGROUNDZhu J, Guo Y, Liu S, Su X, Li Y, Yang Y, Hou L, Wang G, Zhang J, Chen JJ, Wang Q, Wei R, Wei W. Acupuncture for the treatment of gastro-oesophageal reflux disease: a systematic review and meta-analysis. Acupunct Med. 2017 Oct;35(5):316-323. doi: 10.1136/acupmed-2016-011205. Epub 2017 Jul 8.
PMID: 28689187BACKGROUNDEl-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014 Jun;63(6):871-80. doi: 10.1136/gutjnl-2012-304269. Epub 2013 Jul 13.
PMID: 23853213BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Investigator
Study Record Dates
First Submitted
November 27, 2023
First Posted
December 5, 2023
Study Start
December 6, 2023
Primary Completion
March 18, 2024
Study Completion
March 18, 2024
Last Updated
March 20, 2024
Record last verified: 2024-03